Literature DB >> 10416737

Validity and usefulness of the Wisconsin Manual for Assessing Psychotic-like Experiences.

T R Kwapil1, L J Chapman, J Chapman.   

Abstract

The Wisconsin Manual for Assessing Psychotic-like Experiences is an interview-based assessment system for rating psychotic and psychotic-like symptoms on a continuum of deviancy from normal to grossly psychotic. The original manual contained six scales, assessing thought transmission, passivity experiences, thought withdrawal, auditory experiences, personally relevant aberrant beliefs, and visual experiences. A seventh scale assessing deviant olfactory experiences was subsequently added. The rating scales have good interrater reliability when used by trained raters. Cross-sectional studies indicated that the frequency and deviancy of psychotic-like experiences are elevated among college students who were identified, hypothetically, as psychosis prone by other criteria. Psychotic-like experiences of moderate deviancy in college students successfully predicted the development of psychotic illness and poorer overall adjustment 10 years later. The manual is useful for identifying psychosis-prone individuals and is recommended for use in linkage and treatment outcome studies. The present article provides an interview schedule for collecting information required for rating psychotic-like experiences.

Entities:  

Mesh:

Year:  1999        PMID: 10416737     DOI: 10.1093/oxfordjournals.schbul.a033384

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  12 in total

1.  Loose but normal: a semantic association study.

Authors:  C Mohr; R E Graves; L R Gianotti; D Pizzagalli; P Brugger
Journal:  J Psycholinguist Res       Date:  2001-09

2.  The dimensional structure of the Wisconsin Schizotypy Scales: factor identification and construct validity.

Authors:  Thomas R Kwapil; Neus Barrantes-Vidal; Paul J Silvia
Journal:  Schizophr Bull       Date:  2007-09-03       Impact factor: 9.306

3.  The role of aberrant salience and self-concept clarity in psychotic-like experiences.

Authors:  David C Cicero; Theresa M Becker; Elizabeth A Martin; Anna R Docherty; John G Kerns
Journal:  Personal Disord       Date:  2012-03-05

4.  Tailoring the definition of the clinical schizophrenia phenotype in linkage studies.

Authors:  Verena Krause; Olga Krastoshevsky; Michael J Coleman; J Alexander Bodkin; Jan Lerbinger; Lenore Boling; Fred Johnson; Anne Gibbs; Jonathan O Cole; Zhuying Huang; Nancy R Mendell; Deborah L Levy
Journal:  Schizophr Res       Date:  2009-11-26       Impact factor: 4.939

5.  Aberrant salience, self-concept clarity, and interview-rated psychotic-like experiences.

Authors:  David C Cicero; Anna R Docherty; Theresa M Becker; Elizabeth A Martin; John G Kerns
Journal:  J Pers Disord       Date:  2014-08-07

6.  Sex differences in Wisconsin Schizotypy Scales--a meta-analysis.

Authors:  Jouko Miettunen; Erika Jääskeläinen
Journal:  Schizophr Bull       Date:  2008-07-21       Impact factor: 9.306

7.  Correspondence between psychometric and clinical high risk for psychosis in an undergraduate population.

Authors:  David C Cicero; Elizabeth A Martin; Theresa M Becker; Anna R Docherty; John G Kerns
Journal:  Psychol Assess       Date:  2014-04-07

8.  Trajectories of cannabis use disorder: risk factors, clinical characteristics and outcomes.

Authors:  Derek B Kosty; John R Seeley; Richard F Farmer; Joseph J Stevens; Peter M Lewinsohn
Journal:  Addiction       Date:  2016-09-22       Impact factor: 6.526

9.  Spatial working memory ability in individuals at ultra high risk for psychosis.

Authors:  Majella Byrne; Philip McGuire; Vina M Goghari; Caroline Brett; Paul Tabraham; Louise Johns; Lucia Valmaggia; Matthew Broome; James Woolley; Elvira Bramon; Oliver Howes
Journal:  J Psychiatr Res       Date:  2013-12-28       Impact factor: 4.791

Review 10.  The role of schizotypy in the study of the etiology of schizophrenia spectrum disorders.

Authors:  Neus Barrantes-Vidal; Phillip Grant; Thomas R Kwapil
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.